Immunology and immunopathology of African trypanosomiasis by Philippe Vincendeau, Bernard Bouteille

Subjects: Get full text

African Trypanosomiasis Gambiense, Italy by Zeno Bisoffi, Anna Beltrame, Geraldo Monteiro, Alessandra Arzese, Stefania Marocco, Giada Rorato, Mariella Anselmi, Pierluigi Viale

Subjects: “…African trypanosomiasis…”
Get full text

Chemotherapy of Human African Trypanosomiasis by Cyrus J. Bacchi

Get full text

Treatment of human African trypanosomiasis by Michel Dumas, Bernard Bouteille

Get full text

The burden of human African trypanosomiasis. by Eric M Fèvre, Beatrix V Wissmann, Susan C Welburn, Pascal Lutumba

“…Human African trypanosomiasis (HAT, or sleeping sickness) is a protozoan parasitic infection caused by Trypanosoma brucei rhodesiense or Trypanosoma brucei gambiense. …”
Get full text

The detection and treatment of human African trypanosomiasis by Bouteille B, Buguet A

“…Bernard Bouteille,1 Alain Buguet21Laboratory of Parasitology, Dupuytren University Hospital of Limoges, France; 2Polyclinic Marie-Louise Poto-Djembo, Pointe-Noire, CongoAbstract: Human African trypanosomiasis (HAT) is caused by the injection of Trypanosoma brucei (T. b.) gambiense or T. b. rhodesiense by Glossina, the tsetse fly. …”
Get full text

Towards the Atlas of human African trypanosomiasis by Mattioli Raffaele C, Ruiz José A, Diarra Abdoulaye, Fèvre Eric M, Franco José R, Paone Massimo, Cecchi Giuliano, Simarro Pere P

“…<p>Abstract</p> <p>Background</p> <p>Updated, accurate and comprehensive information on the distribution of human African trypanosomiasis (HAT), also known as sleeping sickness, is critically important to plan and monitor control activities. …”
Get full text

Immunophenotypic lymphocyte profiles in human african trypanosomiasis. by Caroline Boda, Bertrand Courtioux, Pierre Roques, Lynda Pervieux, Gédéon Vatunga, Théophile Josenando, Constant Roger Ayenengoye, Bernard Bouteille, Marie-Odile Jauberteau, Sylvie Bisser

“…Human African trypanosomiasis (HAT) is a deadly vector-born disease caused by an extracellular parasite, the trypanosome. …”
Get full text

Therapy of Human African Trypanosomiasis: Current Situation by Jorge Atouguia, José Costa

Subjects: “…human African trypanosomiasis…”
Get full text

Continent-wide attack launched on African trypanosomiasis by John Maurice

Get full text

Elimination of human African trypanosomiasis: The long last mile. by Michael P Barrett, Gerardo Priotto, Jose R Franco, Veerle Lejon, Andreas K Lindner

Get full text

Monitoring the elimination of human African trypanosomiasis: Update to 2014. by José R Franco, Giuliano Cecchi, Gerardo Priotto, Massimo Paone, Abdoulaye Diarra, Lise Grout, Raffaele C Mattioli, Daniel Argaw

“…BACKGROUND:The World Health Organization (WHO) has targeted the elimination of Human African trypanosomiasis (HAT) 'as a public health problem' by 2020. …”
Get full text

Control of human African trypanosomiasis in the Quiçama focus, Angola by Ruiz José Antonio, Simarro Pere P., Josenando Teofilo

Get full text

Cluster of African Trypanosomiasis in Travelers to Tanzanian National Parks by Tomas Jelinek, Zeno Bisoffi, Lucio Bonazzi, Pieter van Thiel, Ulf Bronner, Albie de Frey, Svein Gunnar Gundersen, Paul McWhinney, Diego Ripamont

Subjects: “…African trypanosomiasis…”
Get full text

Multiorgan Dysfunction Caused by Travel-associated African Trypanosomiasis by Lucy E. Cottle, Joanna R. Peters, Alison Hall, J. Wendi Bailey, Harry A. Noyes, Jane E. Rimington, Nicholas J. Beeching, S. Bertel Squire, Mike B.J. Beadsworth

Get full text

Chemical Derivatization and Characterization of Novel Antitrypanosomals for African Trypanosomiasis by Aboagye Kwarteng Dofuor, Temitayo Samson Ademolue, Cynthia Mmalebna Amisigo, Kwaku Kyeremeh, Theresa Manful Gwira

“…The chemical structures of these compounds were confirmed through spectrometric and spectroscopic analysis, and their in vitro efficacy and possible mechanisms of action were, subsequently, investigated in <i>Trypanosoma</i> <i>brucei</i> (<i>T. brucei</i>)<i>,</i> one of the causative species of African trypanosomiasis (AT). The novel compounds <b>2</b> and <b>3</b> displayed significant antitrypanosomal potencies in terms of half-maximal effective concentrations (EC₅₀) and selectivity indices (SI) (compound <b>1</b>, EC₅₀ = 7.3 μM, SI = 29.5; compound <b>2</b>, EC₅₀ = 3.2 μM, SI = 91.3; compound <b>3</b>, EC₅₀ = 4.5 μM, SI = 69.9). …”
Get full text

Human African Trypanosomiasis in the Kafue National Park, Zambia. by David Squarre, Ilunga Kabongo, Musso Munyeme, Chisoni Mumba, Wizaso Mwasinga, Lottie Hachaambwa, Chihiro Sugimoto, Boniface Namangala

Get full text

Prevalence of human African trypanosomiasis in the Democratic Republic of the Congo. by Dieudonne Mumba, Elaine Bohorquez, Jane Messina, Victor Kande, Steven M Taylor, Antoinette K Tshefu, Jeremie Muwonga, Melchior M Kashamuka, Michael Emch, Richard Tidwell, Philippe Büscher, Steven R Meshnick

“…Human African Trypanosomiasis (HAT) is a major public health problem in the Democratic Republic of the Congo (DRC). …”
Get full text

Product Development Partnerships: Delivering Innovation for the Elimination of African Trypanosomiasis? by Emma Michelle Taylor, James Smith

Subjects: Get full text

Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole by Philippe Neau, Heinz Hänel, Valérie Lameyre, Nathalie Strub-Wourgaft, Luc Kuykens

Subjects: Get full text